Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database

Rachel H Mulholland; Eleftheria Vasileiou; Colin R Simpson; Chris Robertson; Lewis D Ritchie; Utkarsh Agrawal; Mark Woolhouse; Josephine Lk Murray; Helen R Stagg; Annemarie B Docherty; Colin McCowan; Rachael Wood; Sarah J Stock; Aziz Sheikh

doi:10.1093/ije/dyab028

Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database

Rachel H Mulholland, Eleftheria Vasileiou^* (Corresponding Author), Colin R Simpson, Chris Robertson, Lewis D Ritchie, Utkarsh Agrawal, Mark Woolhouse, Josephine Lk Murray, Helen R Stagg, Annemarie B Docherty, Colin McCowan, Rachael Wood, Sarah J Stock, Aziz Sheikh

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

30 Citations (Scopus)

Abstract

In December 2019, a novel coronavirus COVID-19 emerged from Wuhan, China, and was soon declared as pandemic by the World Health Organization (WHO) on the 11 March 2020.1 The UK soon followed suit and implemented a national lockdown on the 23 March 2020. As of 9 December 2020, according to WHO, this highly infectious virus has infected more than 67 million people and led to over 1.5 million deaths across the world.2 There is a growing body of evidence on the epidemiology of the condition, risk factors for poor outcomes and effects of interventions.3–9

Original language	English
Pages (from-to)	1064-1074
Number of pages	11
Journal	International Journal of Epidemiology
Volume	50
Issue number	4
Early online date	5 Jun 2021
DOIs	https://doi.org/10.1093/ije/dyab028
Publication status	Published - Aug 2021

Bibliographical note

The original EAVE project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 13/34/14). EAVE II is funded by the Medical Research Council [MR/R008345/1] and supported by the Scottish Government. This work is supported by BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004]. BREATHE is funded through 10 the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.

Keywords

Scotland
surveillance
medical
pandemics
covid-19

Access to Document

10.1093/ije/dyab028Licence: Unspecified

Cite this

Mulholland, R. H., Vasileiou, E., Simpson, C. R., Robertson, C., Ritchie, L. D., Agrawal, U., Woolhouse, M., Murray, J. L., Stagg, H. R., Docherty, A. B., McCowan, C., Wood, R., Stock, S. J., & Sheikh, A. (2021). Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database. International Journal of Epidemiology, 50(4), 1064-1074. https://doi.org/10.1093/ije/dyab028

Mulholland, RH, Vasileiou, E, Simpson, CR, Robertson, C, Ritchie, LD, Agrawal, U, Woolhouse, M, Murray, JL, Stagg, HR, Docherty, AB, McCowan, C, Wood, R, Stock, SJ & Sheikh, A 2021, 'Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database', International Journal of Epidemiology, vol. 50, no. 4, pp. 1064-1074. https://doi.org/10.1093/ije/dyab028

@article{9d86861f649543a489397f88667eed06,

title = "Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database",

abstract = "In December 2019, a novel coronavirus COVID-19 emerged from Wuhan, China, and was soon declared as pandemic by the World Health Organization (WHO) on the 11 March 2020.1 The UK soon followed suit and implemented a national lockdown on the 23 March 2020. As of 9 December 2020, according to WHO, this highly infectious virus has infected more than 67 million people and led to over 1.5 million deaths across the world.2 There is a growing body of evidence on the epidemiology of the condition, risk factors for poor outcomes and effects of interventions.3–9",

keywords = "Scotland, surveillance, medical, pandemics, covid-19",

author = "Mulholland, {Rachel H} and Eleftheria Vasileiou and Simpson, {Colin R} and Chris Robertson and Ritchie, {Lewis D} and Utkarsh Agrawal and Mark Woolhouse and Murray, {Josephine Lk} and Stagg, {Helen R} and Docherty, {Annemarie B} and Colin McCowan and Rachael Wood and Stock, {Sarah J} and Aziz Sheikh",

note = "The original EAVE project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 13/34/14). EAVE II is funded by the Medical Research Council [MR/R008345/1] and supported by the Scottish Government. This work is supported by BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004]. BREATHE is funded through 10 the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. ",

year = "2021",

month = aug,

doi = "10.1093/ije/dyab028",

language = "English",

volume = "50",

pages = "1064--1074",

journal = "International Journal of Epidemiology",

issn = "0300-5771",

publisher = "OXFORD UNIV PRESS",

number = "4",

}

TY - JOUR

T1 - Cohort Profile

T2 - Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database

AU - Mulholland, Rachel H

AU - Vasileiou, Eleftheria

AU - Simpson, Colin R

AU - Robertson, Chris

AU - Ritchie, Lewis D

AU - Agrawal, Utkarsh

AU - Woolhouse, Mark

AU - Murray, Josephine Lk

AU - Stagg, Helen R

AU - Docherty, Annemarie B

AU - McCowan, Colin

AU - Wood, Rachael

AU - Stock, Sarah J

AU - Sheikh, Aziz

N1 - The original EAVE project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 13/34/14). EAVE II is funded by the Medical Research Council [MR/R008345/1] and supported by the Scottish Government. This work is supported by BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004]. BREATHE is funded through 10 the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.

PY - 2021/8

Y1 - 2021/8

N2 - In December 2019, a novel coronavirus COVID-19 emerged from Wuhan, China, and was soon declared as pandemic by the World Health Organization (WHO) on the 11 March 2020.1 The UK soon followed suit and implemented a national lockdown on the 23 March 2020. As of 9 December 2020, according to WHO, this highly infectious virus has infected more than 67 million people and led to over 1.5 million deaths across the world.2 There is a growing body of evidence on the epidemiology of the condition, risk factors for poor outcomes and effects of interventions.3–9

AB - In December 2019, a novel coronavirus COVID-19 emerged from Wuhan, China, and was soon declared as pandemic by the World Health Organization (WHO) on the 11 March 2020.1 The UK soon followed suit and implemented a national lockdown on the 23 March 2020. As of 9 December 2020, according to WHO, this highly infectious virus has infected more than 67 million people and led to over 1.5 million deaths across the world.2 There is a growing body of evidence on the epidemiology of the condition, risk factors for poor outcomes and effects of interventions.3–9

KW - Scotland

KW - surveillance

KW - medical

KW - pandemics

KW - covid-19

U2 - 10.1093/ije/dyab028

DO - 10.1093/ije/dyab028

M3 - Article

C2 - 34089614

SN - 0300-5771

VL - 50

SP - 1064

EP - 1074

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 4

ER -

Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this